-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Calithera Biosciences, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2014 to Q4 2022.
- Calithera Biosciences, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2022 was -$6.94M, a 90% increase year-over-year.
- Calithera Biosciences, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending December 31, 2022 was -$39.7M, a 65.5% increase year-over-year.
- Calithera Biosciences, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$39.7M, a 65.5% increase from 2021.
- Calithera Biosciences, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$115M, a 27.6% decline from 2020.
- Calithera Biosciences, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2020 was -$90.2M, a 0.53% decline from 2019.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)